• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Blockchain is Coming — Ready Or Not, Expert Warns Clinical Research Site Executives

Blockchain is Coming — Ready Or Not, Expert Warns Clinical Research Site Executives

May 29, 2018
William Myers

Blockchain technology offers a lot of promise to sites but it can also destabilize those companies that don’t properly prepare for it, a site executive warned her fellow professionals Tuesday.

When Wendy Charles, the operations manager and researcher at Rocky Mountain Poison & Drug Center at Denver Health asked an audience at the MAGI Clinical Research Conference 2018 East in Arlington, VA, how many had heard of blockchain, very few hands went up. When she asked them how many of their companies were already using blockchain in their business, no hands went up.

“This is coming,” Charles said, “and blockchain will be a part of your everyday life in the near future so it’s important to be aware of what people face.”

Blockchain, sometimes called distributed ledger technology, is a decentralized, digital ledger that tracks transactions across computers. (Its best known example is the cryptocurrency Bitcoin.) It’s already disrupting other industries and it’s appealing to site professionals because it offers transparency, immutability, a clear audit trail and “smart contracting” technologies that promise to make recruiting easier and to give subjects more and better control over the data, Charles said.

The technology has drawbacks, though. The first is that it’s not well understood in the profession, Charles said.

“How does a university prepare for this? How does a site incorporate it?” she asked. “Imagine going to your IRB and saying, ‘Our sponsor would like to put our subject data in the blockchain and the IRB will have all kinds of questions and concerns because they are not familiar with this technology. And they may not even know what kinds of questions to ask in order to ensure that there are appropriate subject protections in place.”

Another concern is the legal and regulatory uncertainties around distributed ledgers, Charles said.

“States are still grappling with how to manage the concept of smart contracts — is that a true contract, especially when used for transactions? The state of Vermont, for example, has put forth legislation to allow notaries in a blockchain — is that legal? They’re trying to make it so. More and more states are looking at the legislation and questions of, ‘Is this binding? Who’s liable?’” she said.

Finally, Charles said, the security risks of distributed ledger technology are “not well known.” In June 2016, for instance, hackers made off with $55 million from a blockchain cryptocurrency fund known as the Decentralized Autonomous Organization by exploiting some of its smart contracting code, Charles said.

If site professionals are considering adopting blockchain technologies, they should focus on three main areas, Charles said:

  1. Permission. Public blockchains (such as Bitcoin) allow literally anyone to make a transaction on them; private ones (already used by big banks, for instance) restrict the people who can make transactions on them. Sites will want to think carefully about who can alter a blockchain — the goal is to secure the chain without over-centralizing the data (thus making any security breaches even more catastrophic), Charles said.
  2. Governance. “It’s an ongoing process,” Charles said and “one of the biggest questions for consortium blockchains because if there’s a group of companies that’s getting together to share a blockchain, who’s in charge? Who makes the decision? Who’s responsible for maintenance? Who’s responsible if there’s a problem?”
  3. Security. “There are vulnerabilities at specific points,” Charles said of distributive ledgers. “Try to think about how often you’ll want to have a risk assessment and what kinds of connections do you want to have with your blockchain.”

IEEE, the nonprofit technology group, runs its own web page dedicated to blockchain in clinical trials, Charles said. You can find it here.

Upcoming Events

  • 12Apr

    The Patient Playbook Webinar Series, Part 3 — Rethinking the Development of Participant-Centric Clinical Trial Technology

  • 25Apr

    Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials

  • 26Apr

    FDA’s New Laws and Regulations: What Drug and Biologics Manufacturers Need to Know

  • 27Apr

    Califf’s FDA, 2023 and Beyond: Key Developments, Insights and Analysis

  • 17May

    2023 WCG Avoca Quality Consortium Summit

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Five Ws

    Consider the Five ‘W’s to Understand Potential Participants

  • QandA-360x240.png

    Perspectives from Smaller-Sized CROs: Q&A with Cheryle Evans

  • White House

    Trial Stakeholders Advise White House on Emergency Research Infrastructure

  • SurveywBlueBackground-360x240.png

    Stress Levels Continue to Climb in Healthcare Workforce, Survey Finds

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing